EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | N021752 | GILEAD SCIENCES INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
GILEAD SCIENCES, INC. et al v. STRIDES PHARMA, INC. et al 6 patentsANDA 091055emtricitabine and tenofovir disoproxil fumarate | D.N.J. | 2018-06-27 | Terminated 2019-01-09 | — |
Gilead Sciences, Inc. et al v. Aurobindo Pharma Ltd. et al 2 patentsANDA 211640emtricitabine and tenofovir disoproxil fumarate | D. Del. | 2018-05-18 | Terminated 2018-10-10 | — |
Gilead Sciences, Inc. et al v. Amneal Pharmaceuticals LLC 2 patentsANDA 209721emtricitabine/tenofovir disoproxil fumarate | D. Del. | 2017-07-13 | Terminated 2018-06-08 | — |
Gilead Sciences, Inc. et al v. Mylan Inc. et al 3 patentsANDA 020636emtricitabine and tenofovir disoproxil fumarate | S.D.N.Y. | 2014-06-02 | Terminated 2014-06-27 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
AIDS Healthcare Foundation (AHF) - Citizen Petition FDA-2012-P-0607 The AIDS Healthcare Foundation filed this citizen petition under section 355(q) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA Commissioner not rely on the Antiviral Drugs Advisory Committee's May 10, 2012 recommendations regarding Gilead Sciences' supplemental New Drug Applicat | 505(q) | 2012-06-12 | Open | — |
AIDS Healthcare Foundation - Citizen Petition FDA-2012-P-0226 The AIDS Healthcare Foundation filed this Section 505(q) citizen petition on March 5, 2012, requesting that the FDA deny Gilead Sciences' supplemental New Drug Application to approve once-daily Truvada (emtricitabine/tenofovir disoproxil fumarate) for pre-exposure prophylaxis to reduce HIV transmiss | 505(q) | 2012-03-20 | Open | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.